Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules C Hancox

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Experimental Physiology|September 27, 2025
Sildenafil helps the beat go onJules C Hancox
Clinical and Experimental Pharmacology & Physiology|June 23, 2017
Could ivabradine be a new treatment for the short QT syndrome?Jules C Hancox
Experimental Physiology|August 9, 2017
A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?Jules C Hancox
Journal of Cardiovascular Electrophysiology|August 2, 2016
Considering Ranolazine as a Potential Treatment for K<sup>+</sup> Channel Linked Short QT SyndromeJules C Hancox
Biochemical and Biophysical Research Communications|August 25, 2004
In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium currentHenggui Zhang, Jules C Hancox
Therapeutic Advances in Drug Safety|September 3, 2020
QT interval prolongation and <i>Torsades de Pointes</i> with donepezil, rivastigmine and galantamineKatie Malone, Jules C Hancox
Circulation Research|March 15, 2003
A novel, voltage-dependent nonselective cation current activated by insulin in guinea pig isolated ventricular myocytesYin Hua Zhang, Jules C Hancox
Expert Opinion on Investigational Drugs|July 2, 2003
Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transportersSheila A Doggrell, Jules C Hancox
Expert Opinion on Investigational Drugs|April 23, 2004
Dronedarone: an amiodarone analogueSheila A Doggrell, Jules C Hancox
Journal of Molecular and Cellular Cardiology Plus|October 23, 2025
Cocaine and the heart - bad news for risk/rewardJules C Hancox, Andrew F James
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Experimental Physiology|September 27, 2025
Sildenafil helps the beat go onJules C Hancox
Clinical and Experimental Pharmacology & Physiology|June 23, 2017
Could ivabradine be a new treatment for the short QT syndrome?Jules C Hancox
Experimental Physiology|August 9, 2017
A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?Jules C Hancox
Journal of Cardiovascular Electrophysiology|August 2, 2016
Considering Ranolazine as a Potential Treatment for K<sup>+</sup> Channel Linked Short QT SyndromeJules C Hancox
Biochemical and Biophysical Research Communications|August 25, 2004
In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium currentHenggui Zhang, Jules C Hancox
Therapeutic Advances in Drug Safety|September 3, 2020
QT interval prolongation and <i>Torsades de Pointes</i> with donepezil, rivastigmine and galantamineKatie Malone, Jules C Hancox
Circulation Research|March 15, 2003
A novel, voltage-dependent nonselective cation current activated by insulin in guinea pig isolated ventricular myocytesYin Hua Zhang, Jules C Hancox
Expert Opinion on Investigational Drugs|July 2, 2003
Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transportersSheila A Doggrell, Jules C Hancox
Expert Opinion on Investigational Drugs|April 23, 2004
Dronedarone: an amiodarone analogueSheila A Doggrell, Jules C Hancox
Journal of Molecular and Cellular Cardiology Plus|October 23, 2025
Cocaine and the heart - bad news for risk/rewardJules C Hancox, Andrew F James
Pageof 23